Rotavirus infection that causes severe dehydration in the patient may have hands in the development of type 1 diabetes, claim researchers.
Rotavirus remains the major cause of infantile gastroenteritis worldwide, although the advent of vaccination has substantially decreased associated mortality.
Following the recent introduction of rotavirus vaccination, there has been a 15% decrease in the incidence of type 1 diabetes in Australian children under four years of age, suggesting that rotavirus vaccination could contribute to the primary prevention of this autoimmune disease.
This finding published in the journal -- PLOS Pathogens -- complemented human and animal studies implicating rotavirus in the development of type 1 diabetes in genetically susceptible children.
In the article, Leonard C. Harrison of the University of Melbourne in Australia, and colleagues begin by reviewing molecular evidence supporting their hypothesis and point out the association between rotavirus infection and serum islet autoantibodies.
They also discuss results indicating that rotavirus infection induces pancreatic pathology, as well as environmental factors that promote the rise in the incidence of type 1 diabetes.
Finally, they reviewed population-level data suggesting that rotavirus vaccination may be associated with a decrease in the incidence of type 1 diabetes.
According to the authors, it will be important to identify which children are most likely to be protected by rotavirus vaccination.
Moreover, future studies should aim to reveal disease mechanisms and directly demonstrate whether rotavirus infects human pancreas prior to the onset of islet autoimmunity or type 1 diabetes.
"Vaccination against rotavirus may have the additional benefit in some children of being primary prevention for type 1 diabetes," Harrison concluded.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
